首页> 外文期刊>Dermatology Online Journal >Toxic epidermal necrolysis due to voriconazole: case report and review
【24h】

Toxic epidermal necrolysis due to voriconazole: case report and review

机译:伏立康唑引起的毒性表皮坏死溶解:病例报告和审查

获取原文
           

摘要

Toxic epidermal necrolysis is an uncommon but potentially life-threatening adverse cutaneous drug reaction characterized by variable degrees of epidermal necrosis and detachment leading to morbidity and risk of mortality. We describe a 67-year-old woman who underwent allogeneic peripheral blood stem cell transplantation as treatment for chronic lymphocytic leukemia. She developed toxic epidermal necrolysis after she was transitioned to voriconazole, which was a component of her post-transplant regimen. The diagnosis of toxic epidermal necrolysis in our patient was made clinically and confirmed histologically. Based on the temporal initiation of voriconazole therapy and the development of her adverse cutaneous reaction, we concluded that voriconazole was the offending agent. There are limited reported cases of voriconazole-induced toxic epidermal necrolysis; we report this case to increase awareness of this potential life-threatening complication.
机译:有毒的表皮坏死溶解是罕见的,但可能危及生命的不良皮肤药物反应,其特征是表皮坏死和脱离程度不同,从而导致发病率和死亡风险。我们描述了接受异体外周血干细胞移植治疗慢性淋巴细胞性白血病的67岁妇女。过渡到伏立康唑后,她发生了毒性的表皮坏死溶解,这是她移植后治疗方案的一部分。在临床上对本组织中毒性表皮坏死进行了诊断,并在组织学上得到了证实。根据伏立康唑治疗的时间开始和她不利的皮肤反应的发展,我们得出结论,伏立康唑是令人讨厌的药物。伏立康唑诱导的毒性表皮坏死溶解病例报道有限;我们报告这种情况是为了提高人们对这种潜在的威胁生命的并发症的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号